InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
6
T+90 hit rate
100%
T+90 mean return
+77.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Martin Michael Robert, Directeur Commercial. Director active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 14 reports have been recorded. Breakdown: 1 buy · 6 sells. Total volume traded: €2.1m. Activity tracked since 11 May 2021. The latest transaction was disclosed on 7 November 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Martin Michael Robert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
107,202 sharesCommon StockSEC:0001628280-23-006529:0
30,000 shares@ US$5.163.0% of flowCommon StockSEC:0001628280-22-029215:0
Canonical exit: 5 Feb 2023 (T+90)
8,500 shares0Common StockSEC:0001628280-22-005130:0
50,000 shares@ US$30.1748.0% of flowCommon SharesSEC:0001628280-21-023169:0
45,000 shares@ US$3.204.6% of flowCommon StockSEC:0001628280-21-021477:0
28,500 shares@ US$5.304.8% of flowCommon StockSEC:0001628280-21-019048:0
44,000 shares@ US$5.307.3% of flowCommon StockSEC:0001628280-21-018782:0
25,000 shares@ US$5.304.1% of flowCommon SharesSEC:0001628280-21-018603:0
7,500 shares@ US$18.104.2% of flowCommon StockSEC:0001628280-21-018219:0
22,500 shares@ US$17.8112.6% of flowCommon StockSEC:0001628280-21-017720:0
5,000 shares@ US$16.012.5% of flowCommon StockSEC:0001628280-21-016403:0
5,000 shares@ US$13.862.2% of flowCommon StockSEC:0001628280-21-014882:0
5,000 shares@ US$13.762.1% of flowCommon StockSEC:0001628280-21-012730:0
20,000 shares@ US$3.021.8% of flowCommon StockSEC:0001628280-21-010021:0
14 of 14 declarations
About Martin Michael Robert
Martin Michael Robert is Directeur Commercial and Chief Business Officer at Aurinia Pharmaceuticals Inc. on XNAS. He has 14 filings, and across the 14 sampled filings between 2021-05-12 and 2023-03-06, buys total EUR 155910 and sells total EUR 1941192, with cession as the modal transaction nature.
